Navigation thread
Molecular pathology of lymphoid neoplasms
Featured projects
-
A single-cell-based solution for an early diagnosis of Richter transformation in patients with chronic lymphocytic leukemia
Principal investigator: Elías Campo Güerri.Funder: European Commission.Code: 101248666.Duration: 01/05/2026 - 31/10/2027Factores de las celulas tumorales y microambiente determinantes de las trayectorias evolutivas del linfoma de células del manto y de la resistencia a nuevas terapias
Principal investigator: Elías Campo Güerri.Funder: Ministerio de Ciencia e Innovación.Code: PID2024-155962OB-I00.Duration: 01/09/2025 - 31/08/2028CLLSYSTEMS: (Epi)Genomic and microenvironment interactions driving evolution in chronic lymphocytic leukemia. Targets for clinical intervention.
Code: LCF/PR/HR22/52420015 (HR22-00172).Duration: 24/07/2023 - 30/11/2025PREGENLINF: Medicina de precisión genómica en neoplasias linfoides
Funder: ISCIII.Code: PMP21/00015.Duration: 01/12/2022 - 30/11/2025Genomic and microenvironment interactions driving evolution in mantle cell lymphoma (MCLSYSTEMS)
Principal investigator: Elías Campo Güerri.Code: PID2021-123054OB-I00.Duration: 01/09/2022 - 30/08/2025Molecular Diagnosis, Prognosis, and Therapeutic Targets in Mantle Cell Lymphoma
Principal investigator: Elías Campo Güerri.Funder: National Institute of Health (NIH).Code: 1P01CA229100.Duration: 01/09/2019 - 31/08/2024Single-cell genomics to comprehensively understand healthy B-cell maturationand transformation to chronic lymphocytic leukemia (BCLLatlas)
Principal investigator: Elías Campo Güerri.Funder: European Commission.Code: H2020-ERC-Sy_2018 (810287).Duration: 01/04/2019 - 31/03/2024CLLEvolution: Genomic and epigenomic drivers of disease evolution in chronic lymphocytic leukemia. Targets for clinical intervention
Principal investigator: Elías Campo Güerri.Funder: La Caixa Foundation.Code: HR17-00221_ LCF/PR/HR17/52150017.Duration: 31/12/2018 - 31/12/2022Caracterización de la inestabilidad genómica y las mutaciones somáticas en linfoma de células del manto y su impacto pronostico
Principal investigator: Sílvia Beà Bobet.Funder: Instituto de Salud Carlos III.Code: PI17/01061.Duration: 01/01/2018 - 30/06/2022Major founders
The research of this group can be carried out thanks to the funders.
-
.This link opens in a new tab. AGAUR
-
.This link opens in a new tab. American Institute for Cancer Research
-
.This link opens in a new tab. Asociación Española Contra el Cáncer
-
.This link opens in a new tab. CIBERonc
-
.This link opens in a new tab. European Commission
-
.This link opens in a new tab. FEDER
-
.This link opens in a new tab. Fundació La Marató de TV3
-
.This link opens in a new tab. Fundació ”la Caixa”
-
.This link opens in a new tab. Generalitat de Catalunya
-
.This link opens in a new tab. Gilead
-
.This link opens in a new tab. Instituto de Salud Carlos III
-
.This link opens in a new tab. Leidos
-
.This link opens in a new tab. Lymphoma Research Foundation
-
.This link opens in a new tab. Ministerio de Economía y Competitividad
-
.This link opens in a new tab. National Institutes of Health
-
.This link opens in a new tab. PERIS
-
.This link opens in a new tab. RTICC
